These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17909068)

  • 41. Expression analysis of Tudor-SN protein in mouse tissues.
    Fashe T; Saarikettu J; Isomäki P; Yang J; Silvennoinen O
    Tissue Cell; 2013 Feb; 45(1):21-31. PubMed ID: 23068188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.
    Gay F; Estornes Y; Saurin JC; Joly-Pharaboz MO; Friederich E; Scoazec JY; Abello J
    Hum Pathol; 2008 Oct; 39(10):1420-30. PubMed ID: 18656242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cdx1 homeobox gene during human colon cancer progression.
    Domon-Dell C; Schneider A; Moucadel V; Guerin E; Guenot D; Aguillon S; Duluc I; Martin E; Iovanna J; Launay JF; Duclos B; Chenard MP; Meyer C; Oudet P; Kedinger M; Gaub MP; Freund JN
    Oncogene; 2003 Sep; 22(39):7913-21. PubMed ID: 12970739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gene amplification and overexpression of PRDM14 in breast cancers.
    Nishikawa N; Toyota M; Suzuki H; Honma T; Fujikane T; Ohmura T; Nishidate T; Ohe-Toyota M; Maruyama R; Sonoda T; Sasaki Y; Urano T; Imai K; Hirata K; Tokino T
    Cancer Res; 2007 Oct; 67(20):9649-57. PubMed ID: 17942894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
    Abal M; Obrador-Hevia A; Janssen KP; Casadome L; Menendez M; Carpentier S; Barillot E; Wagner M; Ansorge W; Moeslein G; Fsihi H; Bezrookove V; Reventos J; Louvard D; Capella G; Robine S
    Gastroenterology; 2007 Jun; 132(7):2448-58. PubMed ID: 17570218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
    Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
    Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
    Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.
    Femia AP; Dolara P; Giannini A; Salvadori M; Biggeri A; Caderni G
    Cancer Res; 2007 Jan; 67(2):445-9. PubMed ID: 17234750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon.
    Lukasiak S; Schiller C; Oehlschlaeger P; Schmidtke G; Krause P; Legler DF; Autschbach F; Schirmacher P; Breuhahn K; Groettrup M
    Oncogene; 2008 Oct; 27(46):6068-74. PubMed ID: 18574467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wnt signaling inside the nucleus.
    Shitashige M; Hirohashi S; Yamada T
    Cancer Sci; 2008 Apr; 99(4):631-7. PubMed ID: 18177486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
    Ghoul A; Serova M; Astorgues-Xerri L; Bieche I; Bousquet G; Varna M; Vidaud M; Phillips E; Weill S; Benhadji KA; Lokiec F; Cvitkovic E; Faivre S; Raymond E
    Cancer Res; 2009 May; 69(10):4260-9. PubMed ID: 19417139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.
    Lee S; Bang S; Song K; Lee I
    Oncol Rep; 2006 Oct; 16(4):747-54. PubMed ID: 16969489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
    Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
    Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Upregulation of beta3-adrenergic receptor mRNA in human colon cancer: a preliminary study.
    Perrone MG; Notarnicola M; Caruso MG; Tutino V; Scilimati A
    Oncology; 2008; 75(3-4):224-9. PubMed ID: 18852493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
    Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
    Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
    Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
    Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PRL-3 expression in metastatic cancers.
    Bardelli A; Saha S; Sager JA; Romans KE; Xin B; Markowitz SD; Lengauer C; Velculescu VE; Kinzler KW; Vogelstein B
    Clin Cancer Res; 2003 Nov; 9(15):5607-15. PubMed ID: 14654542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.